Sen. Heather Steans
Filed: 5/12/2009
|
|||||||
| |||||||
| |||||||
1 | AMENDMENT TO HOUSE BILL 445
| ||||||
2 | AMENDMENT NO. ______. Amend House Bill 445 on page 1, line | ||||||
3 | 5, by inserting "318," after "204,"; and
| ||||||
4 | on page 11, by inserting immediately below line 3 the | ||||||
5 | following:
| ||||||
6 | "(720 ILCS 570/318)
| ||||||
7 | Sec. 318. Confidentiality of information.
| ||||||
8 | (a) Information received by the central repository under | ||||||
9 | Section 316 and 321
is confidential.
| ||||||
10 | (b) The Department must carry out a program to protect the
| ||||||
11 | confidentiality of the information described in subsection | ||||||
12 | (a). The Department
may
disclose the information to another | ||||||
13 | person only under
subsection (c), (d), or (f) and may charge a | ||||||
14 | fee not to exceed the actual cost
of
furnishing the
| ||||||
15 | information.
| ||||||
16 | (c) The Department may disclose confidential information |
| |||||||
| |||||||
1 | described
in subsection (a) to any person who is engaged in | ||||||
2 | receiving, processing, or
storing the information.
| ||||||
3 | (d) The Department may release confidential information | ||||||
4 | described
in subsection (a) to the following persons:
| ||||||
5 | (1) A governing body
that licenses practitioners and is | ||||||
6 | engaged in an investigation, an
adjudication,
or a | ||||||
7 | prosecution of a violation under any State or federal law | ||||||
8 | that involves a
controlled substance.
| ||||||
9 | (2) An investigator for the Consumer Protection | ||||||
10 | Division of the office of
the Attorney General, a | ||||||
11 | prosecuting attorney, the Attorney General, a deputy
| ||||||
12 | Attorney General, or an investigator from the office of the | ||||||
13 | Attorney General,
who is engaged in any of the following | ||||||
14 | activities involving controlled
substances:
| ||||||
15 | (A) an investigation;
| ||||||
16 | (B) an adjudication; or
| ||||||
17 | (C) a prosecution
of a violation under any State or | ||||||
18 | federal law that involves a controlled
substance.
| ||||||
19 | (3) A law enforcement officer who is:
| ||||||
20 | (A) authorized by the Department of State Police or | ||||||
21 | the office of a county sheriff or State's Attorney or
| ||||||
22 | municipal police department of Illinois to receive
| ||||||
23 | information
of the type requested for the purpose of | ||||||
24 | investigations involving controlled
substances; or
| ||||||
25 | (B) approved by the Department to receive | ||||||
26 | information of the
type requested for the purpose of |
| |||||||
| |||||||
1 | investigations involving controlled
substances; and
| ||||||
2 | (C) engaged in the investigation or prosecution of | ||||||
3 | a violation
under
any State or federal law that | ||||||
4 | involves a controlled substance.
| ||||||
5 | (e) Before the Department releases confidential | ||||||
6 | information under
subsection (d), the applicant must | ||||||
7 | demonstrate in writing to the Department that:
| ||||||
8 | (1) the applicant has reason to believe that a | ||||||
9 | violation under any
State or
federal law that involves a | ||||||
10 | controlled substance has occurred; and
| ||||||
11 | (2) the requested information is reasonably related to | ||||||
12 | the investigation,
adjudication, or prosecution of the | ||||||
13 | violation described in subdivision (1).
| ||||||
14 | (f) The Department may receive and release prescription | ||||||
15 | record information to:
| ||||||
16 | (1) a governing
body that licenses practitioners;
| ||||||
17 | (2) an investigator for the Consumer Protection | ||||||
18 | Division of the office of
the Attorney General, a | ||||||
19 | prosecuting attorney, the Attorney General, a deputy
| ||||||
20 | Attorney General, or an investigator from the office of the | ||||||
21 | Attorney General;
| ||||||
22 | (3) any Illinois law enforcement officer who is:
| ||||||
23 | (A) authorized to receive the type of
information | ||||||
24 | released; and
| ||||||
25 | (B) approved by the Department to receive the type | ||||||
26 | of
information released; or
|
| |||||||
| |||||||
1 | (4) prescription monitoring entities in other states | ||||||
2 | per the provisions outlined in subsection (g) and (h) | ||||||
3 | below;
| ||||||
4 | confidential prescription record information collected under | ||||||
5 | Sections 316 and 321 that identifies vendors or
practitioners, | ||||||
6 | or both, who are prescribing or dispensing large quantities of
| ||||||
7 | Schedule II, III, IV, or V controlled
substances outside the | ||||||
8 | scope of their practice, pharmacy, or business, as determined | ||||||
9 | by the Advisory Committee created by Section 320.
| ||||||
10 | (g) The information described in subsection (f) may not be | ||||||
11 | released until it
has been reviewed by an employee of the | ||||||
12 | Department who is licensed as a
prescriber or a dispenser
and | ||||||
13 | until that employee has certified
that further investigation is | ||||||
14 | warranted. However, failure to comply with this
subsection (g) | ||||||
15 | does not invalidate the use of any evidence that is otherwise
| ||||||
16 | admissible in a proceeding described in subsection (h).
| ||||||
17 | (h) An investigator or a law enforcement officer receiving | ||||||
18 | confidential
information under subsection (c), (d), or (f) may | ||||||
19 | disclose the information to a
law enforcement officer or an | ||||||
20 | attorney for the office of the Attorney General
for use as | ||||||
21 | evidence in the following:
| ||||||
22 | (1) A proceeding under any State or federal law that | ||||||
23 | involves a
controlled substance.
| ||||||
24 | (2) A criminal proceeding or a proceeding in juvenile | ||||||
25 | court that involves
a controlled substance.
| ||||||
26 | (i) The Department may compile statistical reports from the
|
| |||||||
| |||||||
1 | information described in subsection (a). The reports must not | ||||||
2 | include
information that identifies, by name, license or | ||||||
3 | address, any practitioner, dispenser, ultimate user, or other | ||||||
4 | person
administering a controlled substance.
| ||||||
5 | (j) Based upon federal, initial and maintenance funding, a | ||||||
6 | prescriber and dispenser inquiry system shall be developed to | ||||||
7 | assist the medical community in its goal of effective clinical | ||||||
8 | practice and to prevent patients from diverting or abusing | ||||||
9 | medications.
| ||||||
10 | (1) An inquirer shall have read-only access to a | ||||||
11 | stand-alone database which shall contain records for the | ||||||
12 | previous 6 months. | ||||||
13 | (2) Dispensers may, upon positive and secure | ||||||
14 | identification, make an inquiry on a patient or customer | ||||||
15 | solely for a medical purpose as delineated within the | ||||||
16 | federal HIPAA law. | ||||||
17 | (3) The Department shall provide a one-to-one secure | ||||||
18 | link and encrypted software necessary to establish the link | ||||||
19 | between an inquirer and the Department. Technical | ||||||
20 | assistance shall also be provided. | ||||||
21 | (4) Written inquiries are acceptable but must include | ||||||
22 | the fee and the requestor's Drug Enforcement | ||||||
23 | Administration license number and submitted upon the | ||||||
24 | requestor's business stationary. | ||||||
25 | (5) No data shall be stored in the database beyond 24 | ||||||
26 | months. |
| |||||||
| |||||||
1 | (6) Tracking analysis shall be established and used per | ||||||
2 | administrative rule. | ||||||
3 | (7) Nothing in this Act or Illinois law shall be | ||||||
4 | construed to require a prescriber or dispenser to make use | ||||||
5 | of this inquiry system.
| ||||||
6 | (8) If there is an adverse outcome because of a | ||||||
7 | prescriber or dispenser making an inquiry, which is | ||||||
8 | initiated in good faith, the prescriber or dispenser shall | ||||||
9 | be held harmless from any civil liability.
| ||||||
10 | (k) Based upon federal and initial and maintenance funding, | ||||||
11 | unless appropriated or otherwise authorized by the General | ||||||
12 | Assembly, a restricted and secure inquiry system shall be | ||||||
13 | developed to assist the law enforcement community in its goal | ||||||
14 | to enforce federal and State law as well as local ordinances | ||||||
15 | related to prescription medications.
Criteria for the inquiry | ||||||
16 | system shall follow the criteria provided in subsection (j), | ||||||
17 | except that the records shall be for the previous 24 months and | ||||||
18 | with the addition that any person making an inquiry must attest | ||||||
19 | that the inquiry is strictly for the purpose of conducting a | ||||||
20 | probable cause investigation only. | ||||||
21 | (Source: P.A. 95-442, eff. 1-1-08.)".
|